Regeneration and functioning of insulin-producing β-cells

Research output: Contribution to journalArticlepeer-review

Abstract

In 1981, we proposed that maintenance of the cellular NAD+ level in pancreatic β-cells of the islets of Langerhans is essential for the synthesis and secretion of insulin and for the repair of β-cell injuries, and presented a unifying model for β-cell damage and its prevention, in which poly(ADP-ribose) synthetase/polymerase (PARP) activation plays an essential role in the depletion of NAD+. In 1984, we demonstrated that the administration of PARP inhibitors to 90% depancreatized rats induces islet regeneration. From the regenerating islet-derived cDNA library we isolated Reg (Regenerating Gene) and demonstrated that Reg protein induces β-cell replication via the Reg receptor and ameliorates experimental diabetes. Recently, we showed that PARP bound to the cis-element of Reg promoter and formed the active transcriptional DNA/protein complex by the stimulation with IL-6 and dexamethasone. The formation was inhibited depending on the autopoly(ADP-ribosyl)ation of PARP in the complex. Thus, PARP inhibitors stabilize the complex formation for Reg gene transcription. In 1993, we found that cyclic ADP-ribose (cADPR), a metabolite of NAD+, is a second messenger for intracellular Ca2+ mobilization for insulin secretion by glucose, and proposed a novel mechanism of insulin secretion, the CD38-cADPR signal system. Therefore, PARP inhibitors prevent β-cell death, induce β-cell replication, and maintain the insulin secretion.

Original languageEnglish
Pages (from-to)14P-17P
JournalFolia Pharmacologica Japonica
Volume118
Issue numberSUPPL. 1
Publication statusPublished - 2001

Keywords

  • CD38
  • Cyclic ADP-ribose
  • Poly(ADP-ribose) synthetase/polymerase (PARP)
  • Reg gene
  • Regeneration

ASJC Scopus subject areas

  • Pharmacology

Fingerprint

Dive into the research topics of 'Regeneration and functioning of insulin-producing β-cells'. Together they form a unique fingerprint.

Cite this